Cizzle Biotechnology (LON:CIZ) Stock Price Up 19.3% – Here’s What Happened

Cizzle Biotechnology Holdings Plc (LON:CIZ)’s share price shot up 19.3% during trading on Friday . The stock traded as high as GBX 1.70 and last traded at GBX 1.67. 619,121 shares changed hands during mid-day trading, an increase of 39% from the average session volume of 444,710 shares. The stock had previously closed at GBX 1.40.

Cizzle Biotechnology Price Performance

The stock has a market capitalization of £6.74 million, a price-to-earnings ratio of -5.31 and a beta of 0.38. The company has a current ratio of 0.48, a quick ratio of 4.66 and a debt-to-equity ratio of -54.35. The company’s 50 day moving average is GBX 1.50 and its 200 day moving average is GBX 1.54.

Cizzle Biotechnology Company Profile

Cizzle Biotechnology Holdings Plc, together with its subsidiaries, engages in the development of an immunoassay test for the CIZ1B biomarker for the early detection of lung cancer in the United Kingdom. The company was formerly known as Cizzle Biotechnology Limited and changed its name to Cizzle Biotechnology Holdings Plc in May 2021. Cizzle Biotechnology Holdings Plc is headquartered in London, the United Kingdom.